Therefore, this study aims to investigate the expression level of serum sLOX-1 in patients with NSCLC and its correlation with lipid metabolism and explore the value of sLOX-1 in the diagnosis of NSCLC. This evidence concerns the gene OLR1 and non-small cell lung carcinoma.